Frankincense and Myrrh Arthritis Pain Relief

Description

Frankincense and Myrrh is a topical analgesic formulated for the temporary relief of pain associated with arthritis. This fast-acting rubbing oil is designed to target joint and muscle discomfort. The formulation contains 2% menthol, which contributes to its analgesic properties. The product is presented in a 2 fluid ounce (59 mL) container.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints, including conditions such as arthritis. It serves as a topical analgesic that targets joint and muscle discomfort, providing fast-acting pain relief.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, the recommended dosage is to apply 10 to 30 drops into the hand and massage into the affected areas. This application may be repeated up to four times daily, as needed.

For children under 12 years of age, it is advised to consult a healthcare professional before use to determine appropriate dosing and administration.

Contraindications

Use is contraindicated in the following situations:

Application on wounds or damaged skin is prohibited due to the potential for adverse effects and impaired healing. Additionally, the product should not be applied over large areas of the body, as this may increase the risk of systemic absorption and associated complications.

Warnings and Precautions

This product is intended for external use only. It is contraindicated for application on wounds or damaged skin and should not be used over large areas of the body.

When utilizing this product, it is imperative to avoid contact with the eyes. Additionally, users should refrain from applying tight bandages over the treated area to prevent complications.

Healthcare professionals should advise patients to discontinue use and seek medical advice if any of the following occur: worsening of the condition, onset of irritation, or if symptoms persist for more than 7 days. Patients should also be instructed to consult a physician if symptoms resolve and then recur within a few days.

It is essential to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. It should not be applied to wounds or damaged skin, nor should it be used over large areas of the body. During use, it is important to avoid contact with the eyes and to refrain from tightly bandaging the area of application.

Patients are advised to discontinue use and consult a healthcare professional if any of the following occur: the condition worsens, irritation develops, or symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

For those who are pregnant or breastfeeding, it is recommended to seek advice from a health professional prior to use. Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Frankincense and Myrrh Arthritis Pain Relief (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a doctor prior to use. For adolescents aged 12 years and older, the recommended dosage is 10-30 drops applied into the hand and massaged into the affected areas, with a maximum frequency of up to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and breastfeeding infants are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with a healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to this population, as the absence of detailed guidance necessitates careful clinical judgment regarding the use of the medication in individuals with reduced kidney function. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product on wounds or damaged skin, and to avoid applying it over large areas of the body. It is important to instruct patients to stop using the product and consult a doctor if their condition worsens, if irritation occurs, or if symptoms persist for more than 7 days. Additionally, patients should be made aware that if symptoms clear up and then recur within a few days, they should also seek medical advice.

While using this product, patients should be cautioned to avoid contact with the eyes. Furthermore, they should be advised not to bandage the area tightly after application to ensure proper use and minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a tamper-resistant container. It is essential to inspect the seal around the bottle neck; do not use the product if the seal is broken or missing.

For optimal storage, the product should be kept in a cool, dry place. Additionally, it is important to retain the carton, as it contains vital information regarding the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Frankincense and Myrrh Arthritis Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)